Evidence map›Paper›PMID 29232858›Full record

ArticleMolecules (Basel, Switzerland)2017

Novel Effective Small-Molecule Antibacterials against Enterococcus Strains.

Kerolos Ashraf, Kaveh Yasrebi, Tobias Hertlein, Knut Ohlsen, Michael Lalk, Andreas Hilgeroth

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kerolos AshrafInstitute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany. kerolos.ashraf@web.de.
Kaveh YasrebiInstitute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany. kaveh.yasrebi@pharmazie.uni-halle.de.ORCID 0000-0002-7411-5340
Tobias HertleinInstitute of Molecular Infection Biology, Julius-Maximilians-University Wuerzburg, 97080 Wuerzburg, Germany. tobias.hertlein@uni-wuerzburg.de.
Knut OhlsenInstitute of Molecular Infection Biology, Julius-Maximilians-University Wuerzburg, 97080 Wuerzburg, Germany. knut.ohlsen@uni-wuerzburg.de.
Michael LalkInstitute of Biochemistry, Ernst-Moritz-Arndt-University Greifswald, 17489 Greifswald, Germany. lalk@uni-greifswald.de.
Andreas HilgerothInstitute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany. andreas.hilgeroth@pharmazie.uni-halle.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsEnterococcusIndolesMicrobial Sensitivity TestsMolecular Structureo-PhthalaldehydeSmall Molecule LibrariesStructure-Activity RelationshipVancomycin ResistanceAnti-Bacterial AgentsindoleIndoleso-PhthalaldehydeSmall Molecule Librariesantibacterial activityderivativeslead structurestructure-activitysynthesis

Identifiers

PMID29232858
PMCPMC6149733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.